The influence of smoking on the treatment response in patients with asthma

  title={The influence of smoking on the treatment response in patients with asthma},
  author={Neil C Thomson and Mark Spears},
  journal={Current Opinion in Allergy and Clinical Immunology},
  • N. Thomson, M. Spears
  • Published 1 February 2005
  • Medicine, Biology
  • Current Opinion in Allergy and Clinical Immunology
Purpose of reviewCigarette smoking and asthma are associated with poor symptom control and impaired therapeutic responses to corticosteroids. We summarize the clinical evidence for corticosteroid resistance, the mechanisms which could be responsible and potential management of this resistance. We also consider the effect smoking has on other drugs commonly used to treat patients with asthma. Recent findingsIn most developed countries the prevalence of active smoking in adults with asthma is… 
Differences in responses upon corticosteroid therapy between smoking and non-smoking patients with COPD.
The results support the evidence that inhaled corticosteroids have no anti-inflammatory effects in COPD patients, but only when these patients are still smoking.
Altered therapeutic response towards inhaled corticosteroids in asthmatics – smokers with mild asthma
More studies are needed in asthmatics determining the asthma symptom score, the number of night awakenings due to asthma, the asthma exacerbations and the frequency of rescue therapy usage which will define the altered therapeutic response to inhaled corticosteroids in smoking asthmatic patients.
Reduced corticosteroid sensitivity in smokers with asthma : potential mechanisms and treatment
The hypothesis that smokers with asthma displayed reduced responses to corticosteroids as a result of a cigarette smoke induced reduction in histone de-acetylase (HDAC) activity is examined, which suggests cigarette smoking in asthma may be associated with a deviation to Th1 mediated inflammation.
The Impact of Smoking on Clinical and Therapeutic Effects in Asthmatics
Asthmatic patients who were former or current smokers showed decreased pulmonary function and increased IgE, emphysema on HRCT, and fixed airway obstruction, indicating that smoking can modulate the clinical and therapeutic responses in asthma.
Influence of cigarette smoking on airway inflammation and inhaled corticosteroid treatment in patients with asthma.
Smokers with asthma showed neutrophilic airway inflammation in addition to eosinophilic inflammation, and cigarette smoking impaired the efficacy of ICS treatment in mild-to-moderate asthma.
Corticosteroid Resistance and Novel Anti-Inflammatory Therapies in Chronic Obstructive Pulmonary Disease
Reversal of corticosteroid resistance in COPD patients by restoringHDAC2 levels has proved effective in a small study, and long-term studies are needed to determine whether novel HDAC2 activators or theophylline improve disease progression, exacerbations or mortality.
Effects of Smoking Cessation on Airflow Obstruction and Quality of Life in Asthmatic Smokers
Both quitters and smokers showed improved QOL scores after 1, 2, and 3 months of fluticasone treatment, suggesting that smoking cessation is crucial in the management of asthma.
[Asthma and smoking: an unfortunate combination].
Resistance to some of the pharmacotherapies used routinely in the treatment of asthma (corticosteroids) has also been observed and this has favored the use of other drugs (antileukotrienes).
The Prevalence of Smoking among Sample of Kuwait Asthmatics and Its Impact on the Response of the Treatment
Smoking was associated with worse asthma control and poor compliance among asthmatics and there was a significant difference in symptoms and signs of bronchial asthma between the 2 groups.